Long noncoding RNA XLOC_006786 inhibits the proliferation, invasion and metastasis of osteosarcoma cells through NOTCH3 signaling pathway by targeting miR-491-5p
Related Experiment Video
Updated: Jul 19, 2025

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
Published on: June 16, 2023
Jia-Yi Xu1, Yang-Fan Lv1, Ya Cao1
1Department of Pathology, Xinqiao Hospital, Army Medical University, Chongqing, China.
Abstract:
Recent research has indicated that Long noncoding RNAs (LncRNAs) are crucial in many disorders, especially tumors. However, the exact role of LncRNA XLOC_006786 (LncRNA-SPIDR-2:1) in malignancies, especially in human osteosarcoma, is unclear. The results of RT‒qPCR, western blotting, CCK-8 assays, and Transwell assays showed that LncRNA XLOC_006786 inhibited osteosarcoma cell proliferation, invasion, and migration, indicating that it may be a tumor suppressor gene in osteosarcoma. We found that LncRNA XLOC_006786 negatively regulated NOTCH3, which is an oncogenic gene in osteosarcoma, as we previously reported. Bioinformatics analysis showed that miR-491-5p may be a direct target of LncRNA XLOC_006786, while NOTCH3 is a key target of miR-491-5p. Then, we verified that LncRNA XLOC_006786 could prevent lung metastatic osteosarcoma in vivo. Taken together, our research showed that LncRNA XLOC_006786 suppresses osteosarcoma proliferation, invasion, and metastasis through the NOTCH3 signaling pathway by targeting miR-491-5p.
Insights
Long noncoding RNA XLOC_006786 acts as a tumor suppressor in osteosarcoma by inhibiting cell proliferation and metastasis. It functions via the miR-491-5p and NOTCH3 signaling pathway, offering potential therapeutic targets.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Long noncoding RNAs (LncRNAs) play significant roles in various diseases, including cancers.
- The specific function of LncRNA XLOC_006786 in human osteosarcoma remains largely uncharacterized.
Purpose of the Study:
- To elucidate the role and mechanism of LncRNA XLOC_006786 in human osteosarcoma.
- To investigate its potential as a tumor suppressor and therapeutic target.
Main Methods:
- Quantitative reverse transcription PCR (RT-qPCR) and Western blotting were used to assess gene and protein expression.
- Cell Counting Kit-8 (CCK-8) and Transwell assays evaluated cell proliferation, invasion, and migration.
- In vivo experiments were conducted to assess the effect on lung metastasis.
Main Results:
- LncRNA XLOC_006786 significantly inhibited osteosarcoma cell proliferation, invasion, and migration.
- LncRNA XLOC_006786 was found to negatively regulate the oncogene NOTCH3.
- Bioinformatics and experimental validation confirmed LncRNA XLOC_006786 targets miR-491-5p, which in turn targets NOTCH3, suppressing tumor growth and metastasis in vivo.
Conclusions:
- LncRNA XLOC_006786 functions as a tumor suppressor in osteosarcoma.
- It exerts its effects by inhibiting proliferation, invasion, and metastasis through the miR-491-5p/NOTCH3 signaling pathway.
Related Concept Videos
MicroRNAs
lncRNA - Long Non-coding RNAs
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Experimental RNAi
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

